Filing Details

Accession Number:
0001127602-19-010077
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-05 19:15:40
Reporting Period:
2019-03-01
Accepted Time:
2019-03-05 19:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646558 David Colleran C/O Insulet Corporation
100 Nagog Park
Acton MA 01720
Svp, Secretary And Gc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-01 16,639 $30.98 47,072 No 4 M Direct
Common Stock Acquisiton 2019-03-01 1,166 $29.26 48,238 No 4 M Direct
Common Stock Acquisiton 2019-03-01 1,422 $46.22 49,660 No 4 M Direct
Common Stock Acquisiton 2019-03-01 1,748 $74.50 51,408 No 4 M Direct
Common Stock Disposition 2019-03-01 20,975 $94.65 30,433 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-01 16,639 $0.00 16,639 $30.98
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-01 1,166 $0.00 1,166 $29.26
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-01 1,422 $0.00 1,422 $46.22
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-01 1,748 $0.00 1,748 $74.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,093 2025-06-29 No 4 M Direct
5,831 2026-02-24 No 4 M Direct
5,686 2027-02-22 No 4 M Direct
5,247 2028-02-14 No 4 M Direct
Footnotes
  1. Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $94.37 to $94.99. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
  4. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.